Texas A&M’s Kyle Field Breaks Record for Game Day Network Data Traffic
Oct 04, 2017 10:06 am UTC| Business
DALLAS, Oct. 04, 2017 -- Tellabs, a leading provider of Passive Optical LAN (OLAN) solutions, is enjoying a 3rd year of superior network performance at Texas AM’s Kyle Field as judged by the 100,000 Aggie football fans...
Oct 04, 2017 10:00 am UTC| Business
Mean Six-Minute Walk Distance Improved in ERT-Naive Patients (+42 Meters at 6 Months, +75 Meters at 9 Months) and ERT-Switch Patients (+35 Meters at 6 Months, +37 Meters at 9 Months) Persistent Durable...
Microbiome Insights recognized in BCIC-New Ventures Competition
Oct 04, 2017 10:00 am UTC| Business
VANCOUVER, British Columbia, Oct. 04, 2017 -- As researchers and companies around the world increasingly recognize the importance of the microbiome, they face a critical gap in expertise, according to one Vancouver...
PICO Holdings, Inc. Announces Sale of Its Stake in Century Communities, Inc.
Oct 04, 2017 10:00 am UTC| Business
LA JOLLA, Calif., Oct. 04, 2017 -- PICO Holdings, Inc. (NASDAQ:PICO) announced today that it has sold its stake of approximately 2.4 million shares of Century Communities, Inc. (NYSE:CCS) for net proceeds of...
Cars Are the Most Dangerous Place for Smart Devices, New Consumer Survey Reveals
Oct 04, 2017 10:00 am UTC| Business
SAN FRANCISCO, Oct. 04, 2017 -- Puls Technologies, Inc., the rapid-response services platform for smart devices, today released findings from its “2017 Smartphone Damage Survey” revealing that although broken...
Trupanion Takes the ‘Shame’ out of Cone of Shame
Oct 04, 2017 10:00 am UTC| Business
SEATTLE, Oct. 04, 2017 -- We’ve all seen those puppy-dog eyes peeping out from a large plastic cone – adorable as ever, our hearts go out to them. Often after medical treatment from veterinarians, our pets must endure...
BioCryst Announces RAPIVAB® (peramivir injection) and Galidesivir Presentations at IDWeek 2017™
Oct 04, 2017 10:00 am UTC| Business
RESEARCH TRIANGLE PARK, N.C., Oct. 04, 2017 -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today that interim results from a clinical trial of a single IV dose of RAPIVAB® (peramivir injection) for the...